Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
Home > Logo Grid Test
A portable MRI compatible surgical robot aiming to improve outcomes in neurosurgery
CNS therapeutic delivery and CSF monitoring device for personalized effective therapy
Functional precision diagnostics to help patients and providers select cancer therapies
A peptide immunotherapeutic vaccine to disrupt cancer in brain tumor patients
Novel therapies targeting cellular motor proteins in oncology and the central nervous system
A new class of molecules that target the aberrant chromatin network in disease
Targeting protein degradation to unlock the full potential of nuclear transport inhibitors
A new class of molecules that selectively kill cancer cells via direct DNA modification (Acquired by Merck in Oct 2024)
